Virtual Reality in Plastic Surgery: Pain Control and Augmented Satisfaction
1 other identifier
observational
40
1 country
1
Brief Summary
The study is looking at whether wearing a virtual reality device will help reduce pain and anxiety during minor procedures
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedStudy Start
First participant enrolled
April 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedAugust 22, 2024
August 1, 2024
1.3 years
April 3, 2019
August 20, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Subjective Pain
Subjective pain measured using the 11-point Numeric Rating Scale (NRS), which is widely employed and is a validated measure of pain (17) at the half way point and 1 minute after the procedure.The scale name is Pain Numeric Rating Scale (NRS) it is a validated scale for graphically measuring pain. The scale range is 0-10 (11 point scale). 0 is no pain. 10 is intolerable pain. The values on this scale will be averaged for each cohort.
1 hour
Blood pressure
Systolic and diastolic blood pressures (mmHg) at the half way point of the procedure as well as 1 minute after completion of the procedure. Blood pressure will be measured as a surrogate measure for objective pain. Blood pressures will be averaged for each cohort. The data will be collected by Dynamap automated Blood pressure monitor.
1 hour
Heart rate
Heart rate at the half way point of the procedure as well as 1 minute after completion of the procedure will be measured in beats per minute using pulse oximetry. Heart rate will be measured as a surrogate measure for objective pain. Heart rates will be averaged for each cohort.
1 hour
Secondary Outcomes (2)
Anxiety
1 hour
Patient Satisfaction
1 hour
Study Arms (2)
Intervention Group: Virtual Reality
Patients will wear a virtual reality device in addition to standard lidocaine/novocaine numbing agent
Control Group: Music
Patients will listen to music in addition to standard lidocaine/novocaine numbing agent
Interventions
A virtual reality device will be worn over the eyes that allows the patient to feel that they are at a quiet seaside beach.
Eligibility Criteria
Patients scheduled for minor elective plastic surgery procedure
You may qualify if:
- Patients scheduled for minor elective plastic surgery procedure
- Patients without cognitive, visual or hearing impairments
You may not qualify if:
- Patients with conditions that may prohibit participation or evaluation of the procedure (such as developmental delay)
- Lesions that involve portions of the head or face that will prohibit the use of VR goggles
- Severe vertigo
- Patients with nausea, vomiting, dementia, motion sickness, stroke, seizure and epilepsy and those placed in isolation (MRSA, VRE) were excluded.
- Patients who are pregnant
- Hearing or visually impaired
- Patients \<18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Robert Packer Hospital
Sayre, Pennsylvania, 18840, United States
Related Publications (1)
Sadik, K. , Miller, M. , Evertsen, N. , Sadik, C. and Bonatti, H. (2023) Virtual Reality in Surgery: Double Blind, Randomized Clinical Trial of Pain Control and Augmented Satisfaction. Surgical Science, 14, 456-467. doi: 10.4236/ss.2023.146050.
RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karim W Sadik, MD
The Guthrie Clinic
- PRINCIPAL INVESTIGATOR
Crystal D Sadik, MD
The Guthrie Clinic
- PRINCIPAL INVESTIGATOR
Nicholas Evertson, MD
The Guthrie Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2019
First Posted
April 16, 2019
Study Start
April 22, 2019
Primary Completion
August 1, 2020
Study Completion
August 1, 2020
Last Updated
August 22, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share